CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Piper Jaffray 22nd Annual Healthcare Conference on Tuesday, November 30, 2010 at 11:30 a.m. ET at The New York Palace.
